ArticleBlood advances2026
Bispecific antibody therapy in multiple myeloma and risk of progressive multifocal leukoencephalopathy.
Jean-Roch Le Henaff et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it